London RX

Currently in process to move from BB M&A to EB RX. In processes with most (LAZ, EVR, PJT, HL, ROTH, GHL, Gleacher… all excluding Moelis basically). Is there a pecking order? I understand PJT comes out on top mostly. Also, how does Morgan Stanley’s Financing and Restructuring team hold up?

22 Comments
 

I thought HL was a top shop for Rx in London, with Lazard being just underneath them ( i think they primarily operate under different sub-sectors, one covers the creditor's side and whatnot). PJT might be better than both tbh but it's important not to conflate US perceptions with London.

Overall its hard to say, all I wanted to emphasise was that HL is pretty good. Maybe not better than PJT

 

I work at one of PJT/HL/LAZ RX in London and my staffer always mentions the other two as main competitors I think it is safe to assume they are very similar. From an analyst perspective, there are differences: HL is RX specific while most juniors are generalists at PJT across Advisory and RX

 

from a pitching perspective, my MD only ever talks about roth/pjt/laz/hl as the competitors in london (im obvs currently at one of the four)

 

I have a contact inside Lazard rx London who was hired specifically for rx but now works on M&A as well due to lack of rx dealflow. His words not mine.

Separately, we need to mention PWP rx in this thread. They aren't topping league tables yet but are gradually rising and hungry for growth. Also pay on par or better than pjt in London

 

Would be interested in PWP as well. Does somebody have insights how they (or London PWP in general) are doing?

 

Dolore est harum omnis autem ea. Similique sed aperiam dolorem illo. Quia id est quo placeat dignissimos debitis qui labore.

Quae quae eveniet sint est. Reprehenderit dolor iure laudantium omnis officia. Qui iure aut sapiente asperiores voluptatem nostrum.

Amet et earum at dolores animi. Iste est qui maiores eum asperiores.

Career Advancement Opportunities

November 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • JPMorgan 01 98.4%
  • Guggenheim Partners 02 97.9%
  • Morgan Stanley 06 97.4%

Overall Employee Satisfaction

November 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 02 99.0%
  • Evercore 01 98.4%
  • Banco Santander 02 97.9%
  • BMO Capital Markets 13 97.4%

Professional Growth Opportunities

November 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • Morgan Stanley 05 98.4%
  • Goldman Sachs 01 97.9%
  • JPMorgan No 97.4%

Total Avg Compensation

November 2026 Investment Banking

  • Vice President (16) $429
  • Associates (57) $264
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (28) $184
  • Intern/Summer Associate (16) $161
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (76) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”